a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CABA has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then PLRX could also see price increases.
Ticker / NAME | Correlation To CABA | 1D Price Change % | ||
---|---|---|---|---|
CABA | 100% | +1.48% | ||
PLRX - CABA | 42% Loosely correlated | +4.74% | ||
ARWR - CABA | 42% Loosely correlated | -0.45% | ||
FATE - CABA | 40% Loosely correlated | -6.00% | ||
ALLO - CABA | 40% Loosely correlated | +0.49% | ||
RCKT - CABA | 40% Loosely correlated | +1.36% | ||
More |